🇺🇸 Prenisolone in United States
28 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 28
Most-reported reactions
- Anaemia — 5 reports (17.86%)
- Drug Ineffective — 5 reports (17.86%)
- Condition Aggravated — 3 reports (10.71%)
- Hypotension — 3 reports (10.71%)
- Acute Myocardial Infarction — 2 reports (7.14%)
- Blood Albumin Decreased — 2 reports (7.14%)
- Blood Potassium Decreased — 2 reports (7.14%)
- Diarrhoea — 2 reports (7.14%)
- Drug Exposure During Pregnancy — 2 reports (7.14%)
- Dry Eye — 2 reports (7.14%)
Other Other approved in United States
Frequently asked questions
Is Prenisolone approved in United States?
Prenisolone does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Prenisolone in United States?
Bristol-Myers Squibb is the originator. The local marketing authorisation holder may differ — check the official source linked above.